These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys. Emery JC; Dodd PJ; Banu S; Frascella B; Garden FL; Horton KC; Hossain S; Law I; van Leth F; Marks GB; Nguyen HB; Nguyen HV; Onozaki I; Quelapio MID; Richards AS; Shaikh N; Tiemersma EW; White RG; Zaman K; Cobelens F; Houben RMGJ Elife; 2023 Dec; 12():. PubMed ID: 38109277 [TBL] [Abstract][Full Text] [Related]
6. [Impact of HIV and Zheng ZG; Geng WK; Lu ZZ; Li JJ; Zhou CX; Yang WM Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1362-1367. PubMed ID: 30453438 [No Abstract] [Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications. Ryckman TS; Dowdy DW; Kendall EA Proc Natl Acad Sci U S A; 2022 Dec; 119(52):e2211045119. PubMed ID: 36534797 [TBL] [Abstract][Full Text] [Related]
9. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa. Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764 [TBL] [Abstract][Full Text] [Related]
11. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression. Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401 [TBL] [Abstract][Full Text] [Related]
12. Association of Baya B; Diarra B; Diabate S; Kone B; Goita D; Sarro YDS; Cohen K; Holl JL; Achenbach CJ; Tolofoudie M; Togo ACG; Sanogo M; Kone A; Kodio O; Dabitao D; Coulibaly N; Siddiqui S; Diop S; Bishai W; Dao S; Doumbia S; Murphy RL; Diallo S; Maiga M Am J Trop Med Hyg; 2020 Jan; 102(1):36-41. PubMed ID: 31733052 [No Abstract] [Full Text] [Related]
13. Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells. Abebe F Clin Exp Immunol; 2021 Apr; 204(1):32-40. PubMed ID: 33315236 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940 [TBL] [Abstract][Full Text] [Related]
15. Genome scan of M. tuberculosis infection and disease in Ugandans. Stein CM; Zalwango S; Malone LL; Won S; Mayanja-Kizza H; Mugerwa RD; Leontiev DV; Thompson CL; Cartier KC; Elston RC; Iyengar SK; Boom WH; Whalen CC PLoS One; 2008; 3(12):e4094. PubMed ID: 19116662 [TBL] [Abstract][Full Text] [Related]
17. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road? Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979 [TBL] [Abstract][Full Text] [Related]
18. Feasibility of novel approaches to detect viable Alebouyeh S; Weinrick B; Achkar JM; García MJ; Prados-Rosales R Front Med (Lausanne); 2022; 9():965359. PubMed ID: 36072954 [TBL] [Abstract][Full Text] [Related]
19. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]